BMRN stock

Analyst Snapshot

BMRN’s earnings forecast for the current quarter

Kenneth Phillips

Currently, Biomarin Pharmaceutical Inc’s (BMRN) stock is trading at $55.36, marking a fall of -1.28% from last night’s close. At ...

Financial Scores

Biomarin Pharmaceutical Inc (BMRN) stock: A year of ups and downs

Preston Campbell

While Biomarin Pharmaceutical Inc has underperformed by -1.57%, investors are advised to look at stock chart patterns for technical insight. ...

Market Summary

Biomarin Pharmaceutical Inc (BMRN)’s stock price in review: A technical analysis

Patricia Turner

While Biomarin Pharmaceutical Inc has overperformed by 0.75%, investors are advised to look at stock chart patterns for technical insight. ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.